FDA approves label updates for BMS’ CAR T cell therapies
Bristol Myers Squibb (BMS) has announced that the US Food and Drug Administration (FDA) has given approval to label updates …
Post
-
-
AI in drug discovery: from hypothetical to reality
AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to revolutionise how …
-
Viatris gains China approval for Yupelri to treat COPD
Theravance Biopharma’s partner Viatris has received China's National Medical Products Administration (NMPA) approval for Yupelri (revefenacin) inhalation solution for maintenance …
-
Novo Nordisk teams up with WeightWatchers in latest telehealth push
Novo Nordisk has bounced back from a sour ending to its Hims & Hers partnership, revealing a new deal with …
-
Why can’t the US figure out weight loss drug prices?
“I'm in London, and I just paid for this damn fat drug I take. I said, it's not working. They …
-
Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies
Porton Advanced Solutions and EVA Pharma have signed a memorandum of understanding (MoU) to enhance the development and manufacturing capabilities …
-
Vor Bio back from brink with autoimmune drug deal rising to $4bn
A month and a half after winding operations and laying off almost all its staff, Vor Bio has emerged from …
-
BioCity’s SC0062 gains NMPA breakthrough therapy designation
The Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted BioCity's endothelin receptor type A …
-
Innovation in Focus: Highlights from the Two-Day London Biotechnology Show 2025
The London Biotechnology Show 2025 opened to a dynamic two-day run at ExCeL London, offering a rich blend of insightful …
-
UK steps up with £1.25bn Gavi vaccine pledge as US funding disappears
The UK has confirmed its support for global vaccination by pledging £1.25bn to global vaccine group Gavi while the US …
-
Eli Lilly receives FDA approval for Amyvid label update
The US Food and Drug Administration (FDA) has granted approval for a label update to Eli Lilly and Company's Amyvid …
-
How AI and machine learning are transforming drug discovery
AI is revolutionizing drug discovery with its ability to analyze vast datasets. Particularly beneficial in the early drug discovery phase, …
-
Novartis concludes Regulus Therapeutics acquisition
Novartis has completed its previously announced acquisition of US-based biopharmaceutical company Regulus Therapeutics for $1.7bn, strengthening its renal disease portfolio. Shares …
-
Gilead eyes Kymera’s ‘adhesive’ cancer drug in $750m deal
Fresh off a regulatory victory for a new HIV product, Gilead is shifting focus to the oncology space – signing …
-
Navigating uncertainty: the future of vaccine oversight amid CDC firings
In a controversial move on 9 June 2025, US Secretary of Health and Human Services Robert F Kennedy Jr dismissed …
